Selectins are a family of integral membrane glycoproteins that mediate adhesion between leukocytes and endothelial cells during the transient rolling phase of leukocyte migration.
Selectins are a family of integral membrane glycoproteins that mediate adhesion between leukocytes and endothelial cells during the transient rolling phase of leukocyte migration. [1] [2] [3] The selectin family consists of three glycoprotein members: E-, P-and L-selectins. E-and P-selectins are expressed on activated endothelium, whereas L-selectin is constitutively expressed on neutrophils, monocytes, and most lymphocytes. P-selectin mediates attachment and is translocated to the surface of the endothelium within minutes of activation. E-selectin mediates slow rolling and is expressed after several hours on the activated cell surface. 4, 5) Each selectin has a calcium-dependent carbohydrate binding domain (C-type lectin domain) in its amino-terminal, followed by an epidermal growth factor-like domain, variable numbers of complement regulatory-like units, a transmembrane domain and an intracellular region. The adhesion activity of the selectins is mediated primarily by the binding of sialyl Lewis X (sLe X ) (NeuAca2→3Galb1→4(Fuca1→3)GlcNAc-R, Fig. 1 ) on the leukocyte to the carbohydrate-binding domain on activated endothelial cells. [6] [7] [8] [9] [10] [11] In a productive immune response, this leads to isolation of infection; however, overzealous transfer of leukocytes causes widespread tissue damage, leading to several disease states, such as reperfusion injury, cardiovascular diseases, and allergic diseases. 5) Inhibition of selectin-mediated rolling is a possible means of controlling inflammation-induced diseases. Therefore, the development of selectin inhibitors, which are able to control the leukocyte-endothelia cell adhesion process, is an excellent therapeutic target to treat inflammatory diseases.
It is well known that all selectins recognize the carbohydrate structure of sLe X and sialyl Lewis a (sLe a ), an isomer of sLe X ; therefore, most reported selectin inhibitors are carbohydrate-based molecules mimicking sLe X or sLe a and antibodies. 5, [12] [13] [14] [15] [16] [17] [18] [19] [20] However, they have drawbacks as therapeutics, i.e., carbohydrate chains are difficult to synthesize in high yield and purity, and carbohydrate-based molecules are generally prone to rapid metabolism and elimination. On the other hand, antibodies have potential immunogenicity, high cost, and other possible side effects.
The phage-displayed library is a representative method based on affinity binding between the displayed library and the target molecule or tissue. Recently, cloning of carbohydrate mimetic peptides within a short term has become available by the phage-displayed peptide library method. Several peptides mimicking carbohydrate have been found using phage-displayed libraries. [21] [22] [23] [24] [25] [26] O et al. also identified the dodecapeptide (DLWDWVVGKPAG) mimicking sLe a by screening a phage-displayed library using monoclonal antibody NS19-9.
27)
Generally, the synthesis of a long peptide in high yield and purity is difficult, and long or large peptides have relatively high antigenicity. Thus, short peptides are necessary to overcome the therapeutic drawbacks. In this study, we tried to find the octapeptide mimicking structure of sLe X carbohydrate using a chemical peptide library method. The peptide library was constructed by the mix-split method, 28) which is one of the most reliable methods of constructing peptide libraries. We utilized synthetic octapeptide libraries containing sub-libraries in which an amino acid was fixed at one designated position while randomized at other positions, and tested their binding affinities to monoclonal anti-sialyl Lewis X antibody 2H5 (anti-sLe X MAb 2H5). As a result, we succeeded in finding a novel octapeptide mimicking sLe X carbohydrate as a selectin inhibitor.
Here we describe the identification of an octapeptide sequence (YRNWFGRW) and its evaluation as a selectin inhibitor. PO 4 ). After blocking the plate with 1% bovine serum albumin (BSA) and PBS containing 0.05% Tween 20 (TPBS), 100 ml anti-sLe X MAb 2H5 (2 mg/ml) solution was added to each well. After 2 h incubation at room temperature (r.t.), the plate was washed with TPBS 3 times, and incubated for 2 h with horseradish peroxidase (HRP)-labeled anti-mouse IgM goat antibody (second antibody, molar enzyme antibody ratio 4 : 1, 1 mg/ml, 100 ml/well; KPL, Gaithersburg, MA, U.S.A.). Visualization was performed using tetramethyl benzidine (TMB) micro-well peroxidase substrate (KPL). Absorbance was measured at 450 nm using a microplate reader (Model 680 XR; Bio-Rad).
MATERIALS AND METHODS

Antibodies and Peptide
Synthetic Octapeptide Library The octapeptide library was constructed by fluorenylmethoxycarbonyl (Fmoc) based solid-phase methodology using the mix-split method. 28 ) For the peptide library, 18 natural L-amino acids (excluding cysteine and methionine) were used, starting with Fmoc-NH SAL resin (Watanabe Chemical Industries Ltd., Hiroshima, Japan). Fmoc amino acids with the following side chain-protecting groups were used: 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulphonyl (Pbf) for arginine, tertiary butyl ether (tert-Bu) for aspartic acid, glutamic acid, serine, threonine and tyrosine, tert-butoxycarbonyl (Boc) for lysine and tryptophan, trityl (Trt) for asparagine and glutamine, 4-methyltrityl (Mtt) for histidine. Amino acids were coupled with 2-(1-H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), 1-hydroxybenzotriazole (HOBt), and diisopropylethylamine (DIPEA) for 1 h, and the Fmoc group was removed with a solution containig 2% piperidine and 2% 1,8-diazabicycloundecene (DBU) in N,N-dimethylformamide (DMF). After the establishment of peptides on resin, the peptides were cleaved from the resin using a solution of 5% triethylsilane in trifluoroacetic acid (TFA) for 1 h at r.t.
29) The peptide mixture was triturated thoroughly with absolute ether to remove deblocking reagents, and then used for screening.
Screening of Peptides Mimicking sLe X from Octapeptide Library Synthetic dodecapeptide, H-DLWDWVVGK-PAG-NH 2 , was used as an antigen peptide in the enzyme linked immunosorbent assay (ELISA). Antigen peptides were adsorbed on 96-well microplates (10 mg/ml, 100 ml/well) overnight at 4°C. After blocking the plates with 1% BSA and TPBS, anti-sLe X MAb 2H5 (2 mg/ml, 50 ml/well) and samples (2 mg/ml, 50 ml/well) were added to each well. After 2 h incubation, each plate was washed with TPBS and incubated 2 h with the second antibody bearing HRP (1 mg/ml, 100 ml/well). Visualization was performed using TMB micro-well peroxidase substrate. Absorbance (Abs) was measured at 450 nm with a microplate reader. The bound rate (%) of anti-sLe X MAb 2H5 was determined using the following formula: [bound MAb 2H5 (%)ϭ(sample AbsϪ nonspecific Abs)/(total AbsϪnonspecific Abs)ϫ100]. These data were obtained from at least three separate assays.
Determination of IC 50 of Octapeptide (H-YRNWF-GRW-NH 2 ) to Anti-sLe X MAb 2H5 The antigens, sLe X or synthetic H-DLWDWVVGKPAG-NH 2 , were adsorbed on a 96-well microplate overnight at 4°C. After blocking the plate with 1% BSA and TPBS, 100 ml anti-sLe X MAb 2H5 (2 mg/ml) solution was added to each well. After incubation for 1 h, each plate was washed with TPBS and then incubatd for 1 h with 100 ml carbohydrate mimetic peptide solution. The plate was washed with TPBS and subjected to 1 h incubation with the second antibody bearing HRP (0.5 mg/ml, 100 ml/well). Visualization was performed using TMB micro-well peroxidase substrate. Absorbance was measured at 450 nm using a microplate reader. IC 50 values were determined using data from at least three separate assays and logarithm dose-displacement curves.
Synthesis of Alanine-Scanning and Dansyl Labeled Analogues Alanine-scanning peptide analogues were synthesized by the Fmoc-based solid-phase method, starting with Fmoc-NH SAL-resin. Fmoc-amino acids with the following side chain protecting groups were used: Fmoc-Ala-OH, Fmoc-Tyr(tert-Bu)-OH, Fmoc-Arg(Pbf)-OH, FmocAsn(Trt)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Phe-OH, FmocGly-OH. Amino acid coupling and Fmoc group removal were performed with the same method as for the synthetic octapeptide library. For fluorescent labeling, resin-bound peptides were treated with dansyl chloride (Dns-Cl, 3-fold excess) and DIPEA (6-fold excess) dissolved in DMF, leading to the formation of resin-bound N-terminal Dns-labeled peptides. After completion of the synthesis, the peptide was cleaved from the resin using reagent K (TFA : thioanisole : H 2 O : phenol : 1,2-ethandithiolϭ82.5 : 5 : 5 : 5 : 2.5) for 1 h at r.t. The peptide analogues were purified by HPLC using Develosil ODS-UG-5 (10ϫ250 mm; Nomura Chemical Co., Ltd. Aichi, Japan) eluted with a linear gradient of 0.06% TFA in H 2 O and 0.06% TFA in CH 3 OH. Electrospray ionization mass spectrometry (ESI-MS) was conducted using a JEOL AccuTOF mass spectrometer. Amino acid analysis was performed on a 4000QTRAP LC-MS (Applied Biosystems) using a Develosil RPAQUEOUS-AR-5 column (2ϫ150 mm, Nomura Chemical Co., Ltd.). The samples were eluted with a linear gradient of 100% A to 80% A/20% B over 25 min at a flow rate of 0.2 ml/min. Solvents A and B were 5 mM heptafluorobutyric acid (HFBA) in H 2 O and 5 mM HFBA in CH 3 CN, respectively. Analytical samples were hydrolyzed in 20% HCl for 24 h at 110°C.
Binding Property of Alanine-Scanning Analogues to Anti-sLe X MAb 2H5 The synthetic octapeptide, H-YRN-WFGRW-NH 2 , was adsorbed on a 96-well microplate overnight at 4°C. After blocking the plate with 1% BSA and TPBS, 100 ml anti-sLe X MAb 2H5 (2 mg/ml) solution was added to each well. After 1 h incubation, each plate was washed with TPBS and subjected to 1 h incubation with 100 ml alanine-scanning analogues solution. The plate was washed with TPBS and subjected to 1 h incubation with the second antibody bearing HRP (0.5 mg/ml, 100 ml/well). Visualization was performed using TMB micro-well peroxidase substrate. Absorbance was measured at 450 nm using a microplate reader. IC 50 values were determined using data from at least three separate assays and logarithm dose-displacement curves.
Binding Affinity of H-YRNWFGRW-NH 2 for Recombinant Human E-Selectin
Human recombinant E-selectin IgG 6ϫHis (10 mM; R&D Systems) was fixed on nickelcoated 96-well plates (HisGrab TM ; Pierce or Immobilizer Nichelate; Nunc) for 1 h at 25°C or over night at 4°C. The Eselectin solution was removed, and then the plate was incubated with sLe X -PAA-Fluor (GlycoTech) or Dns-YRNWF-GRW-NH 2 for 1 h at 25°C. The plate was washed twice with PBS containing 0.9 mM CaCl 2 and 0.6 mM MgCl 2 (PBSϩ). Nonspecific binding was determined with 100 mM nonlabeled sLe X or peptide. And competitive binding assay was used 10 mM Dns-YRNWFGRW-NH 2 and 1-100 mM sLe X . After incubation for 1 h, the plate was washed three times with PBSϩ. Fluorescent measurements were performed using Infinit M200 (Dns: ex 340 nm, em 565 nm, Fluor: ex 488 nm, em 520 nm; Tecan).
RESULTS
Screening of Peptide Libraries Against Anti-sLe
X MAb 2H5 First, we investigated whether the synthetic dodecapeptide (H-DLWDWVVGKPAG-NH 2 ) mimicking sLe a carbohydrate, which was identified by O et al. could be used as an ELISA antigen in our screening experiments. Binding of dodecapeptide to anti-sLe X MAb 2H5 was dose-dependent and saturated at higher concentrations (more than 2 mg/ml, data not shown). This result suggests that dodecapeptide has high affinity for anti-sLe X MAb 2H5, and could cross-react with anti-sLe X MAb 2H5. Accordingly, H-DLWDWVVGK-PAG-NH 2 was used as the antigen for screening the chemical peptide library.
We found a novel octapeptide (H-YRNWFGRW-NH 2 ) with high affinity for anti-sLe X MAb 2H5 using the chemical peptide library. The identification process was as follows: O in H-OXXXXXXX-NH 2 is individually defined from 18 natural L-amino acids, omitting cysteine and methionine. X is a random combination of the 18 amino acids. The result of the inhibitory effect of the peptide library mixture on the binding of anti-sLe X MAb 2H5 to H-DLWDWVVGKPAG-NH 2 absorbed to the 96-well micro plate is shown in Fig. 2 . The first position was determined to be a tyrosine (Y) residue, because the Y library inhibited MAb binding more strongly than the other libraries (Fig. 2a) . Based on the screening result, secondary libraries were synthesized containing Y at the first position (e.g. H-Y-OXXXXXX-NH 2 ). Library subsets were synthesized based on the adjacent screening results. In the second position, three kinds of libraries, containing histidine (H), arginine (R), and tyrosine (Y), inhibited MAb binding more strongly than the other libraries. We chose an R residue in this screening, because the result of the R library had a smaller error bar than the other libraries (Fig. 2b) . In this way, all 8 positions were determined based on inhibitory activity of anti-sLe X MAb 2H5 binding and the stability of the result. Consequently, the octapeptide sequence was determined to be H-YRNWFGRW-NH 2 ; however, the inhibitory activities of the peptide libraries to anti-sLe X MAb 2H5 were not notably improved in the course of the peptide sequence determination (for example, the 3rd, 5th and 6th positions), so inhibitory activity in the last library (H-YRNWFGRW-NH 2 ) was tested again in each screening step.
As shown in Fig. 3 , each screening step peptide showed significantly higher inhibitory potency than the former library. Furthermore, this octapeptide potently inhibited the binding of anti-sLe X MAb 2H5 to dodecapeptide, although its IC 50 (9.68 nM) was slightly lower than that (3.98 nM) of dodecapeptide. From these results, the determined peptide sequence was constructed Binding Affinity of H-YRNWFGRW-NH 2 for Anti-sLe X MAb 2H5 To elucidate the binding inhibitory of the identified octapeptide (H-YRNWFGRW-NH 2 ) for anti-sLe X MAb 2H5 bound to sLe X , the binding potency (IC 50 ) was determined. The octapeptide competitively inhibited the interaction between anti-sLe X MAb 2H5 and sLe X in a dose-dependent manner, the same as the carbohydrate mimetic dodecapeptide (H-DLWDWVVGKPAG-NH 2 ), as shown in Fig. 4 . In addition, the inhibitory potency of the octapeptide for this interaction (IC 50 ; 17.8 nM) was almost the same as that (IC 50 ; 18.5 nM) of dodecapeptide (as shown in Table 1 ). These results suggested that the identified octapeptide was able to inhibit the interaction between anti-sLe X MAb 2H5 and sLe X ; however, the octapeptide did not clearly show direct binding affinity for anti-sLe X MAb 2H5. To elucidate the direct binding of the octapeptide to anti-sLe X MAb 2H5, the octapeptide was adsorbed on a microplate. The octapeptide showed binding affinity for anti-sLe X MAb 2H5 (IC 50 ; 3.83 nM). This Binding Affinity of Alanine-Scanning Analogues to Anti-sLe X MAb 2H5 To confirm important residues in the identified octapeptide for interaction with anti-sLe X MAb 2H5, we synthesized alanine-scanning analogues of H-YRN-WFGRW-NH 2 . All analogues gave satisfactory amino acid analytical and ESI-MS data ( Table 2 ). The binding affinity of analogues to anti-sLe X MAb 2H5 was determined using ELISA. As shown in Fig. 5 , the inhibitory effect of analogues of anti-sLe X MAb 2H5 was reduced, except [Ala5]. In particular, substitution of R and W residues at position 7 and 8, resulted in a marked drop in affinity. In addition, substitution of two aromatic amino acid residues, Y and W, at positions 1 and 4, resulted in a drop in affinity. These results suggest that aromatic and cationic amino acid residues, particular at the 7th and 8th positions, have a key role in interacting with antisLe X MAb 2H5. Conversely, the 5th and 6th positions showed less specific binding to anti-sLe X MAb 2H5. This result is agreement with the result of the sequence determination screening (Fig. 2) .
Binding Affinity of H-YRNWFGRW-NH 2 for Recombinant Human E-Selectin As it was confirmed that the identified octapeptide could be recognized as sLe X analogue by anti-sLe X MAb 2H5, the binding affinity of the octapeptide for human E-selectin was investigated. As shown in Fig. 6 , the binding behavior of Dns-YRNWFGRW-NH 2 to E-selectin was dose-dependent and more specific than that of sLe X -PAA-Fluor. The octapeptide had a lower binding constant (K d ) value (0.168 mM) than that (0.415 mM) of sLe X , the endogenous ligand of E-selectin. Furthermore, sLe X inhibited between the octapeptide and human E-selectin in a dosedependent manner (Fig. 7) . These results suggest that the identified octapeptide is a high affinity ligand for human E-selectin. The recombinant human E-selectin was fixed immobilizer Ni-chelate plate and then Dns-YRNWFGRW-NH 2 was bound to E-selectin following incubation with sLe X at 1-100 mM. Each point represents the mean with at least three separate experiments.
